• Angiotensin I Workflows for RAS Research

  2026-09-08

  Build reproducible renin-angiotensin system experiments around Angiotensin I as a defined substrate for ACE conversion, cardiovascular pathway studies, and antihypertensive screening. The workflow also shows how recent peptide-binding findings can guide carefully controlled cross-domain assays without confusing precursor activity with downstream Ang II effects.

• Engineering a Single-Component Bitespiramycin Strain

  2026-09-08

  Ma et al. simplified bitespiramycin biosynthesis by deleting part of the sspA 3-O-acyltransferase gene in Streptomyces spiramyceticus WSJ-1. The resulting WSJ-2 strain preferentially produced 400-isovalerylspiramycin I, illustrating how targeted pathway engineering can reduce antibiotic component complexity and improve downstream characterization.

• HA-LNP PTEN mRNA for Transdermal Immunotherapy

  2026-09-07

  The reference study develops a hyaluronate-conjugated lipid nanoparticle in which HA-DMG replaces conventional PEG-lipid functions while enabling CD44-oriented delivery of PTEN mRNA through skin. In a melanoma model, topical PTEN mRNA@HA-LNP restored tumor-suppressor expression, promoted immunogenic cell death, activated antitumor immunity, and reduced tumor growth with limited reported toxicity.

• Etomoxir: From FAO Inhibition to Translational Design

  2026-09-07

  Etomoxir and R-(+)-Etomoxir provide a powerful framework for connecting mitochondrial fatty acid oxidation with immune function, lipid remodeling, and neuroinflammatory disease models. This thought-leadership guide explains how to interpret CPT-1 inhibition, design whole-blood and cellular assays, manage DGAT-related confounding, and translate findings without overstating therapeutic relevance.

• N2703 in Adipose-Neural Cardiac Assays

  2026-09-05

  Use 3-(1-methylpyrrolidin-2-yl)pyridine (N2703) as a controlled perturbation in adipocyte–neuron–cardiomyocyte experiments inspired by an emerging arrhythmia mechanism. A staged workflow combines solvent discipline, pathway controls, electrophysiology, calcium imaging, and viability gates so exploratory findings are not mistaken for target validation.

• Cytosolic DNA Rewires TDP-43 Homeostasis

  2026-09-04

  The reference study identifies cytosolic DNA accumulation as a trigger of TDP-43 condensate formation, nuclear depletion, and production of a short TDP-43 isoform. Its findings connect DNA mislocalization, nuclear transport, phase separation, and ALS-linked TDP-43 dysfunction, while offering a framework for studying DNA damage-related mechanisms in neurodegeneration.

• Budesonide B1900 for Reliable Cell Assays

  2026-09-04

  Learn how Budesonide (SKU B1900) can help researchers distinguish anti-inflammatory activity from assay artefacts in viability, proliferation, and airway inflammation studies. This scenario-based guide covers solvent compatibility, stock preparation, protocol controls, permeability-model interpretation, and practical supplier selection.

• Negative Electrostatics in α-Synuclein Condensates

  2026-09-03

  The reference study shows that α-synuclein condensates are not electrostatically neutral compartments: their strongly negative potential controls the partitioning of proteins, fluorophores, and small molecules. By combining charge-varied probes, zeta-potential analysis, and a differentiated SH-SY5Y model, the work provides a framework for interpreting condensate composition and designing fluorescence-based experiments.

• Mecamylamine hydrochloride for Gut-Brain Studies

  2026-09-03

  Mecamylamine hydrochloride provides a practical pharmacological stress test for nicotinic acetylcholine receptor signaling in neuronal, gut-brain, and neuropsychiatric models. This guide connects receptor-level assays with vagal recordings, microbiota experiments, seizure phenotyping, and troubleshooting strategies while clearly separating reported evidence from workflow recommendations.

• Hexetidine (NSC-17764) for Oral Biofilm Assays

  2026-09-02

  Hexetidine (NSC-17764) supports strain-aware planktonic testing, Candida work, and biofilm inhibition assays in oral microbiology. Its distinctive value is the opportunity to quantify copper synergy while preserving practical controls for solubility, inoculum effects, and biofilm readout variability.

• NSP15 Inhibitor Screening: Thymopentin and Oleuropein

  2026-09-02

  The 2021 reference study used structure-based virtual screening and molecular dynamics to prioritize natural products that may inhibit the SARS-CoV-2 endoribonuclease NSP15. Thymopentin and oleuropein produced the most favorable computational profiles, but the findings remain a preclinical hypothesis requiring biochemical, cellular, and pharmacokinetic validation.

• SNAI1–PIK3R2/p-EphA2 Axis in Thymic Tumors

  2026-09-01

  This 2024 study identifies SNAI1 as a transcriptional hub that promotes epithelial–mesenchymal transition, invasion, and cancer stem cell-like properties in thymic epithelial tumors. Multi-omics and functional experiments connect SNAI1 to a PIK3R2/p-EphA2 signaling axis and provide a mechanistic framework for investigating aggressive thymic tumor biology.

• Chlorin e6 Workflows for PDT Research

  2026-09-01

  Chlorin e6 enables controllable ROS-based experiments in anticancer photodynamic therapy and antibacterial wound scaffolds. This practical guide connects formulation, light dosimetry, assay design, and troubleshooting with findings from an aligned silk-fibroin platform.

• Chemistry of Silybin: Structure and Research Utility

  2026-08-31

  Křen and colleagues provide a comprehensive chemistry-focused review of silybin, tracing its isolation, stereochemical assignment, separation, synthesis, and systematic derivatization. The study’s practical value lies in showing how structural definition and chemical modification can improve interpretation of flavonolignan research, especially when complex Silymarin mixtures are used in biological assays.

• (S)-(+)-Ibuprofen: Reliable Cell Assays

  2026-08-31

  A scenario-based guide to using (S)-(+)-Ibuprofen as a defined COX inhibitor in cell viability, proliferation, and cytotoxicity workflows. It explains dosing, solvent compatibility, interpretation, protocol controls, and vendor-selection considerations for SKU B1018.

8101 records 1/541 page Next 12345 下5页 Last page